Press Releases
Bacchus Vascular Names Eric Heil
as Vice President of Sales
Senior Sales Executive Adds Experience to Growing Medical Device Company
Santa Clara, CA – November 5, 2007 – Bacchus Vascular Inc., a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of deep vein thrombosis (DVT) and other peripheral vascular disease, announced today that it has named Eric Heil to the position of Vice President of Sales.
Mr. Heil fills the position vacated by former Senior Vice President of Sales Scott Cramer when he was named President and CEO of Bacchus Vascular in October, 2007.
Mr. Heil has over 18 years of sales and sales management experience in the healthcare and medical device arena with a focus in endovascular specialties. Prior to joining Bacchus, he was the Vice President of Sales and Development for Partners Imaging. Previously, he served as Vice President of Sales for Chase Medical where he was responsible for global sales for the organization. Mr. Heil also held various sales and sales management positions with VNUS Medical Technologies, Endosonics/JOMED, Cardiometrics Inc., DeRoyal Cardiovascular and The Upjohn Company. Eric holds a BA degree from The University of North Texas.
“Eric Heil has a proven background in the vascular disease and interventional field, a strong track record of introducing innovative medical technologies, and proven success developing new markets,” said Scott Cramer, President and CEO of Bacchus Vascular. “Eric brings tremendous experience to Bacchus Vascular, and we anticipate continued growth with Eric heading our sales organization.”
About Bacchus Vascular
Bacchus Vascular, Inc. is a venture-backed medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure. Thousands of patients suffering from DVT and other occlusive vascular diseases have been treated worldwide to date using the company’s Trellis® Peripheral Infusion System and other products.
Media Contact
Dennis Rosenberg
Vice President, Marketing
408-980-8300, ext. 260
drosenberg@bacchusvascular.com